AUM91F ;IHS/SD/DMJ,SDR,GTH - ICD 9 CODES FOR FY 2009 ; [ 08/18/2003   4:01 PM ]
 ;;10.2;TABLE MAINTENANCE;;MAR 09, 2010
 ;
ICD9NEW3 ;
 ;;611.81^Ptosis of breast^Ptosis of breast^^9^600,601
 ;;611.82^Hypoplasia of breast^Hypoplasia of breast^^9^600,601
 ;;611.83^Capsular cntractre breast impl^Capsular contracture of breast implant^^9^600,601
 ;;611.89^Oth spec disorders of breast^Other specified disorders of breast^^9^600,601
 ;;612.0^Deformity of recnstruct breast^Deformity of reconstructed breast^^9^600,601
 ;;612.1^Disprop of reconstrcted breast^Disproportion of reconstructed breast^^9^600,601
 ;;625.70^Vulvodynia, unspecified^Vulvodynia, unspecified^F^13^742,743,760,761
 ;;625.71^Vulvar vestibulitis^Vulvar vestibulitis^F^13^742,743,757,758,759
 ;;625.79^Other vulvodynia^Other vulvodynia^F^13^742,743,760,761
 ;;649.70^Cerv shortng unspec care or NA^Cervical shortening, unspecified as to episode of care or not applicable^F^14^998
 ;;649.71^Cerv shtng del w/w/o antep cnd^Cervical shortening, delivered, with or without mention of antepartum condition^F^14^765,766,767,768,774,775
 ;;649.73^Cerv shrtng antepar cond or cc^Cervical shortening, antepartum condition or complication^F^14^781,782
 ;;678.00^Fetl hema cnds unsp care or NA^Fetal hematologic conditions, unspecified as to episode of care or not applicable^F^14^998
 ;;678.01^Fetl hema cnds del w/w/o antep^Fetal hematologic conditions, delivered, with or without mention of antepartum condition^F^14^765,766,767,768,774,775
 ;;678.03^Fetal hemat cndtns antep cond^Fetal hematologic conditions, antepartum condition or complication^F^14^781,782
 ;;678.10^Fetl conj twns unsp care or NA^Fetal conjoined twins, unspecified as to episode of care or not applicable^F^14^998
 ;;678.11^Fetl conj twns del w/w/o antep^Fetal conjoined twins, delivered, with or without mention of antepartum condition^F^14^765,766,767,768,774,775
 ;;678.13^Fetl conjnd twns antep cond cc^Fetal conjoined twins, antepartum condition or complication^F^14^781,782
 ;;679.00^Mat cc in utero unspec care/NA^Maternal complications from in utero procedure, unspecified as to episode of care or not applicable^F^14^765,766,767,768,774,775
 ;;679.01^Mat cc in utro del w/w/o antep^Maternal complications from in utero procedure, delivered, with or without mention of antepartum condition^F^14^765,766,767,768,774
 ;;679.02^Mat cc in utro prc del w/pp cc^Maternal complications from in utero procedure, delivered, with mention of postpartum complication^F^14^765,766,767,768,774
 ;;679.03^Mat cc in utero proc antepart^Maternal complications from in utero procedure, antepartum condition or complication^F^14^781,782
 ;;679.04^Mat cc in utero proc postpart^Maternal complications from in utero procedure, postpartum condition or complication^F^14^769,776
 ;;679.10^Fetl cc in utr prc unsp careNA^Fetal complications from in utero procedures, unspecified as to episode of care or not applicable^F^14^998
 ;;679.11^Fetl cc in utro del w/w/o antp^Fetal complications from in utero procedures, delivered, with or without mention of antepartum condition^F^14^765,766,767,768,774,775
 ;;679.12^Fetl cc utro prc del w/pp cc^Fetal complications from in utero procedures, delivered, with mention of postpartum complication^F^14^765,766,767,768,774,775
 ;;679.13^Fetl cc in utro prc antep cond^Fetal complications from in utero procedures, antepartum condition or complication^F^14^781,782
 ;;679.14^Fetl cc in utr proc postp cond^Fetal complications from in utero procedures, postpartum condition or complication^F^14^769,776
 ;;695.10^Erythema multiforme, unspec^Erythema multiforme, unspecified^^9^595,596
 ;;695.11^Erythema multiforme minor^Erythema multiforme minor^^9^595,596
 ;;695.12^Erythema multiforme major^Erythema multiforme major^^9^595,596
 ;;695.13^Stevens-Johnson syndrome^Stevens-Johnson syndrome^^9^595,596
 ;;695.14^Stev-Johns synd toxic epi necr^Stevens-Johnson syndrome-toxic epidermal necrolysis overlap syndrome^^9^595,596
 ;;695.15^Toxic epidermal necrolysis^Toxic epidermal necrolysis^^9^595,596
 ;;695.19^Other erythema multiforme^Other erythema multiforme^^9^595,596
 ;;695.50^Exfol eryth inv <10 body surf^Exfoliation due to erythematous condition involving less than 10 percent of body surface^^9^606,607
 ;;695.51^Exfol eryth inv 10-19 body sur^Exfoliation due to erythematous condition involving 10-19 percent of body surface^^9^606,607
 ;;695.52^Exfol eryth inv 20-29 body sur^Exfoliation due to erythematous condition involving 20-29 percent of body surface^^9^606,607
 ;;695.53^Exfol eryth inv 30-39 body sur^Exfoliation due to erythematous condition involving 30-39 percent of body surface^^9^606,607
 ;;695.54^Exfol eryth inv 40-49 body sur^Exfoliation due to erythematous condition involving 40-49 percent of body surface^^9^606,607
 ;;695.55^Exfol eryth inv 50-59 body sur^Exfoliation due to erythematous condition involving 50-59 percent of body surface^^9^606,607
 ;;695.56^Exfol eryth inv 60-69 body sur^Exfoliation due to erythematous condition involving 60-69 percent of body surface^^9^606,607
 ;;695.57^Exfol eryth inv 70-79 body sur^Exfoliation due to erythematous condition involving 70-79 percent of body surface^^9^606,607
 ;;695.58^Exfol eryth inv 80-89 body sur^Exfoliation due to erythematous condition involving 80-89 percent of body surface^^9^606,607
 ;;695.59^Exfol eryth inv > 90% body sur^Exfoliation due to erythematous condition involving 90 percent or more of body surface^^9^606,607
 ;;707.20^Pressure ulcer, unspec stage^Pressure ulcer, unspecified stage^^9^573,574,575,592,593,594
 ;;707.21^Pressure ulcer, stage I^Pressure ulcer, stage I^^9^573,574,575,592,593,594
 ;;707.22^Pressure ulcer, stage II^Pressure ulcer, stage II^^9^573,574,575,592,593,594
 ;;707.23^Pressure ulcer, stage III^Pressure ulcer, stage III^^9^573,574,575,592,593,594
 ;;707.24^Pressure ulcer, stage IV^Pressure ulcer, stage IV^^9^573,574,575,592,593,594
 ;;707.25^Pressure ulcer, unstageable^Pressure ulcer, unstageable
 ;;729.90^Disorders soft tissue, unspec^Disorders of soft tissue, unspecified^^8^555,556
 ;;729.91^Post-traumatic seroma^Post-traumatic seroma^^8^555,556
 ;;729.92^Nontrauma hematoma soft tissue^Nontraumatic hematoma of soft tissue^^8^555,556
 ;;729.99^Other disorders of soft tissue^Other disorders of soft tissue^^8^555,556
 ;;733.96^Stress fracture-femoral neck^Stress Fracture of femoral neck
 ;;733.97^Stress fracture-shaft of femur^Stress fracture of shaft of femur
 ;;733.98^Stress fracture-pelvis^Stress fracture of pelvis
 ;;760.61^Newbn affcted by amniocentesis^Newborn affected by amniocentesis^^15^794
 ;;760.62^NB affct by oth in utero proce^Newborn affected by other in utero procedure^^15^794
 ;;760.63^NB aff oth surg op on moth prg^Newborn affected by other surgical operations on mother during pregnancy^^15^794
 ;;760.64^NB aff surg, mo not asoc w/prg^Newborn affected by previous surgical procedure on mother not associated with pregnancy^^15^794
 ;;777.50^Necrotzng entercolitis NB Unsp^Necrotizing enterocolitis in newborn, unspecified^^15^791,793
 ;;777.51^Stg I necro entercolitis in NB^Stage I necrotizing enterocolitis in newborn^^15^791,793
 ;;777.52^Stg II necro enterclitis in NB^Stage II necrotizing enterocolitis in newborn^^15^791,793
 ;;777.53^Stg III necro entrclitis in NB^Stage III necrotizing enterocolitis in newborn^^15^791,793
 ;;780.60^Fever, unspecified^Fever, unspecified
 ;;780.61^Fever w conditn class elswhre^Fever presenting with conditions classified elsewhere
 ;;780.62^Postprocedural fever^Postprocedural fever
 ;;780.63^Postvaccination fever^Postvaccination fever
 ;;780.64^Chills (without fever)^Chills (without fever)
 ;;780.65^Hypotherm not assoc w low temp^Hypothermia not associated with low environmental tempurature
 ;;780.72^Functional quadriplegia^Functional quadriplegia^^1^52,53
 ;;788.91^Functionl urinary incontinence^Functional urinary incontinence^^11^695,696
 ;;788.99^Oth symptoms inv urinary syst^Other symptoms involving urinary system^^11^695,696
 ;;795.07^Sat cerv smr lackg transf zone^Satisfactory cervical smear but lacking transformation zone^F^13^742,743,760,761
 ;;795.10^Abn glandr Pap smear vagina^Abnormal glandular Papanicolaou smear of vagina^F^13^742,743,760,761
 ;;795.11^Pap smr vagina with ASC-US^Papanicolaou smear of vagina with atypical squamous cells of undetermined significance (ASC-US)^F^13^742,743,760,761
 ;;795.12^Pap smr vagina with ASC-H^Papanicolaou smear of vagina with atypical squamous cells cannot exclude high grade squamous intraepithelial lesion (ASC-H)^F^13^742,743,760,761
 ;;795.13^Pap smr vagina with LGSIL^Papanicolaou smear of vagina with low grade squamous intraepithelial lesion (LGSIL)^F^13^742,743,760,761
 ;;795.14^Pap smr vagina with HGSIL^Papanicolaou smear of vagina with high grade squamous intraepithelial lesion (HGSIL)^F^13^742,743,760,761
 ;;795.15^Vag high rsk HPV DNA test pos^Vaginal high risk human papillomavirus (HPV) DNA test positive^F^13^742,743,760,761
 ;;795.16^Pap smr vag w/cyto evid malign^Papanicolaou smear of vagina with cytologic evidence of malignancy^F^13^742,743,760,761
 ;;795.18^Unsat vaginal cytology smear^Unsatisfactory vaginal cytology smear^F^13^742,743,760,761
 ;;795.19^Oth abn Pap smr vag/vagnal HPV^Other abnormal Papanicolaou smear of vagina and vaginal HPV^F^13^742,743,760,761
 ;;796.70^Abnr glandular Pap smear anus^Abnormal glandular Papanicolaou smear of anus^^6^393,394,395
 ;;796.71^Pap smr anus with ASC-US^Papanicolaou smear of anus with atypical squamous cells of undetermined significance (ASC-US)^^6^393,394,395
 ;;796.72^Pap smr anus w/atypcl sq cells^Papanicolaou smear of anus with atypical squamous cells cannot exclude high grade squamous intraepithelial lesion (ASC-H)^^6^393,394,395
 ;;796.73^Pap smr anus with LGSIL^Papanicolaou smear of anus with low grade squamous intraepithelial lesion (LGSIL)^^6^393,394,395
 ;;796.74^Pap smear anus with HGSIL^Papanicolaou smear of anus with high grade squamous intraepithelial lesion (HGSIL)^^6^393,394,395
 ;;796.75^Anal high rsk HPV DNA test pos^Anal high risk human papillomavirus (HPV) DNA test positive^^6^393,394,395
 ;;796.76^Pap smr anus w/cyto evd malign^Papanicolaou smear of anus with cytologic evidence of malignancy^^6^393,394,395
 ;;796.77^Satsf anal smr lckng trnfor zn^Satisfactory anal smear but lacking transformation zone^^6^393,394,395
 ;;796.78^Unsatsfactry anal cytolgy smr^Unsatisfactory anal cytology smear^^6^393,394,395
 ;;796.79^Oth abno Pap smr anus/anal HPV^Other abnormal Papanicolaou smear of anus and anal HPV^^6^393,394,395
 ;;997.31^Ventilator assoc pneumonia^Ventilator associated pneumonia^^4^205,206
 ;;997.39^Oth respiratory complications^Other respiratory complications^^4^205,206
 ;;998.30^Disruption of wound,unspecif^Disruption of wound, unspecified^^21^919,920,921
 ;;998.33^Disruptn traumatc wound repair^Disruption of traumatic wound repair^^21^919,920,921
 ;;999.81^Extravas of vesicant chemother^Extravasation of vesicant chemotherapy^^5^314,315,316
 ;;999.82^Estravas of Oth vesicant agent^Extravasation of other vesicant agent^^5^314,315,316
 ;;999.88^Other infusion reaction^Other infusion reaction^^5^314,315,316
 ;;999.89^Other transfusion reaction^Other transfusion reaction^^15^791,793
 ;;END
PRNT ;
 S U="^"
 W !," CODE",?10,"DIAGNOSIS",!?10,"DESCRIPTION",!," -----",?10,"-----------"
 NEW X,Y,P2,P3
 F X=1:1 S Y=$P($T(ICD9NEW+X),";;",3),P2=$P(Y,U,2),P3=$P(Y,U,3) Q:Y="END"  W !," ",$P(Y,U,1),?10,$S($L(P3):P3,1:P2),!?10,P2
 Q
